| scholarly article | Q13442814 |
| P356 | DOI | 10.1200/JCO.2005.05.516 |
| P698 | PubMed publication ID | 16116151 |
| P50 | author | Yair Lotan | Q61862568 |
| Craig Rogers | Q88616638 | ||
| Pierre I Karakiewicz | Q97332033 | ||
| Arthur I. Sagalowsky | Q114316665 | ||
| Seth P. Lerner | Q114316685 | ||
| Ganesh S Palapattu | Q114404137 | ||
| Amnon Vazina | Q114404138 | ||
| Gilad E Amiel | Q114404139 | ||
| Paul Perotte | Q114404159 | ||
| Shahrokh Shariat | Q7462263 | ||
| Mark Joseph Schoenberg | Q11770302 | ||
| P2093 | author name string | Amit Gupta | |
| Patrick J Bastian | |||
| P433 | issue | 27 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lymph node | Q170758 |
| Radical cystectomy | Q111329312 | ||
| P304 | page(s) | 6533-6539 | |
| P577 | publication date | 2005-08-22 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy | |
| P478 | volume | 23 |
| Q38051444 | A contemporary update on pathology reporting for urinary bladder cancer |
| Q37641597 | A greater number of dissected lymph nodes is associated with more favorable outcomes in bladder cancer treated by radical cystectomy: a meta-analysis |
| Q38817683 | A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapy |
| Q52569036 | A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer. |
| Q50062164 | Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder |
| Q43917433 | Accurate preoperative prediction of non-organ-confined bladder urothelial carcinoma at cystectomy |
| Q37771961 | Adjuvant and neoadjuvant radiotherapy for bladder cancer: revisited |
| Q46613374 | Adjuvant chemotherapy for bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control study |
| Q84883989 | Age ≥ 80 years is independently associated with survival outcomes after radical cystectomy: results from the Canadian Bladder Cancer Network Database |
| Q30414136 | Altered expression of transmembrane mucins, MUC1 and MUC4, in bladder cancer: pathological implications in diagnosis |
| Q37033849 | Apparent diffusion coefficient value for estimating clinicohistological factors in bladder cancer including infiltration style and lymphatic invasion |
| Q37278983 | Bladder cancer: clinical and pathological profile |
| Q34684041 | Breast carcinomatous tumoral emboli can result from encircling lymphovasculogenesis rather than lymphovascular invasion |
| Q53130577 | Change in Management Based on Pathologic Second Opinion Among Bladder Cancer Patients Presenting to a Comprehensive Cancer Center: Implications for Clinical Practice. |
| Q80274704 | Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomy |
| Q41471527 | Clinical and therapeutic factors associated with adverse pathological outcomes in clinically node-negative patients treated with neoadjuvant cisplatin-based chemotherapy and radical cystectomy |
| Q35533836 | Clinical, demographic and histopathological prognostic factors for urothelial carcinoma of the bladder |
| Q40381359 | Comparative analysis of the effect of prostatic invasion patterns on cancer-specific mortality after radical cystectomy in pT4a urothelial carcinoma of the bladder |
| Q36953757 | Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy. |
| Q37953115 | Comprehensive handbook for developing a bladder cancer cystectomy database |
| Q38206405 | Contemporary gender-specific outcomes in Germany after radical cystectomy for bladder cancer |
| Q41346526 | Copy number variations of circulating, cell-free DNA in urothelial carcinoma of the bladder patients treated with radical cystectomy: a prospective study |
| Q34104562 | Critical review of prostate cancer predictive tools |
| Q37789085 | Current chemotherapeutic options for the treatment of advanced bladder cancer: A review |
| Q84603668 | Delays in diagnosis and bladder cancer mortality |
| Q46700456 | Distribution of lymphatic vessel network in normal urinary bladder |
| Q41737126 | Does the extent of variant histology affect oncological outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy? |
| Q83219199 | Does the greater number of lymph nodes removed during standard lymph node dissection predict better patient survival following radical cystectomy? |
| Q42677000 | Early oncological outcomes for bladder urothelial carcinoma patients treated with robotic-assisted radical cystectomy |
| Q94956640 | Editorial comment |
| Q50459477 | Editorial comment from Dr Tsuzuki to Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: a population-based study. |
| Q39592589 | Effect of tumor location on survival in urinary bladder adenocarcinoma: A population-based analysis |
| Q44426851 | Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy |
| Q36095244 | Evaluating the quality of colorectal cancer care in the state of Florida: results from the Florida Initiative for Quality Cancer Care |
| Q86989630 | Expression and predictive value of lymph-specific markers in urothelial carcinoma of the bladder |
| Q92610282 | Expression and prognostic utility of PD-L1 in patients with squamous cell carcinoma of the bladder |
| Q38303587 | Extent of pelvic lymph node dissection during radical cystectomy: is bigger better? |
| Q36612618 | First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours |
| Q35934764 | High VEGF-D and Low MMP-2 Serum Levels Predict Nodal-Positive Disease in Invasive Bladder Cancer. |
| Q35592277 | Histological variant as the significant predictor of survival in patients with lymph node positive urothelial carcinoma of the bladder |
| Q33339210 | Hydronephrosis is an independent predictor of poor clinical outcome in patients treated for muscle-invasive transitional cell carcinoma with radical cystectomy |
| Q53175159 | Immediate radical cystectomy vs conservative management for high grade cT1 bladder cancer: is there a survival difference? |
| Q41441646 | In cystectomy specimens with bladder cancer whole organ embedding increases the detection rate of histopathological parameters, but not of those with prognostic significance |
| Q85222296 | Intravesical tumor involvement of the trigone is associated with nodal metastasis in patients undergoing radical cystectomy |
| Q46425203 | Invasion patterns and metastasis of urothelial carcinoma. A challenge for translational research |
| Q84267636 | Long-term survival and onset of granulomatous pneumonia after lung metastasectomy in a patient with non-muscle-invasive bladder cancer |
| Q85109899 | Longitudinal evaluation of the concordance and prognostic value of lymphovascular invasion in transurethral resection and radical cystectomy specimens |
| Q38427531 | Loss expression of uroplakin III is associated with clinicopathologic features of aggressive bladder cancer |
| Q84190566 | Lymphangiogenesis and cancer metastasis |
| Q80179110 | Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy |
| Q82277093 | Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma |
| Q81521507 | Lymphovascular invasion and pathologic tumor stage are significant outcome predictors for patients with upper tract urothelial carcinoma |
| Q40020263 | Lymphovascular invasion as a predictive factor for muscle-invasive bladder cancer and its importance in a bladder-conservation treatment group |
| Q58107187 | Lymphovascular invasion have a similar prognostic value as lymph node involvement in patients undergoing radical cystectomy with urothelial carcinoma |
| Q84218618 | Lymphovascular invasion in radical cystectomy specimen: is it an independent prognostic factor in patients without lymph node metastases? |
| Q43196454 | Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial |
| Q46906313 | Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy |
| Q37331994 | Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. |
| Q58113597 | Management of High-grade T1 Urothelial Carcinoma |
| Q36634023 | Molecular markers of prognosis and novel therapeutic strategies for urothelial cell carcinomas |
| Q81373078 | Muscle-invasive bladder cancer: predictive factors and prognostic difference between primary and progressive tumors |
| Q33559656 | Nestin is an independent predictor of cancer-specific survival after radical cystectomy in patients with urothelial carcinoma of the bladder |
| Q91644071 | OSblca: A Web Server for Investigating Prognostic Biomarkers of Bladder Cancer Patients |
| Q38252387 | Optimal treatment of non-muscle invasive urothelial carcinoma including perioperative management revisited |
| Q50493416 | Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy. |
| Q85377312 | Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis |
| Q37373576 | Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration |
| Q37214749 | P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors |
| Q49380161 | Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature. |
| Q37424793 | Persistent uroplakin expression in advanced urothelial carcinomas: implications in urothelial tumor progression and clinical outcome |
| Q30437629 | Personalized medicine in advanced urothelial cancer: when to treat, how to treat and who to treat |
| Q36986098 | Poor prognostic value of lymphovascular invasion for pT1 urothelial carcinoma with squamous differentiation in bladder cancer |
| Q36474159 | Practical use of perioperative chemotherapy for muscle-invasive bladder cancer: summary of session at the Society of Urologic Oncology annual meeting |
| Q37103989 | Predicting survival after radical cystectomy for bladder cancer |
| Q46489162 | Predictors of cancer-specific mortality after disease recurrence following radical cystectomy |
| Q37227652 | Preoperative hydronephrosis as an indicator of survival after radical cystectomy |
| Q88291700 | Prognostic importance of lymphovascular invasion in urothelial carcinoma of the renal pelvis |
| Q35816480 | Prognostic significance of lymphovascular invasion in bladder cancer after surgical resection: A meta-analysis |
| Q37807077 | Prognostic significance of lymphovascular invasion in radical prostatectomy specimens |
| Q44920495 | Prognostic significance of lymphovascular invasion in upper urinary tract urothelial carcinoma is influenced by tumor location |
| Q38176436 | Radical cystectomy and the implications of comorbidity |
| Q41450928 | Recurrence of Urothelial Bladder Carcinoma in the Colon Presenting as Hematochezia |
| Q30408866 | Refining patient selection for neoadjuvant chemotherapy before radical cystectomy |
| Q43557462 | Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: a population-based study |
| Q84854504 | Retrospective analysis of survival in muscle-invasive bladder cancer: impact of pT classification, node status, lymphovascular invasion, and neoadjuvant chemotherapy |
| Q26773664 | Risk based neoadjuvant chemotherapy in muscle invasive bladder cancer |
| Q41462223 | Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder |
| Q84904080 | Risk stratification of survival by lymphovascular invasion, pathological stage, and surgical margin in patients with bladder cancer treated with radical cystectomy |
| Q37335474 | Risk-adapted use of intravesical immunotherapy. |
| Q44893721 | Robotic-assisted radical cystectomy with extracorporeal urinary diversion for urothelial carcinoma of the bladder: analysis of complications and oncologic outcomes in 175 patients with a median follow-up of 3 years |
| Q52584563 | SPAG5 promotes proliferation and suppresses apoptosis in bladder urothelial carcinoma by upregulating Wnt3 via activating the AKT/mTOR pathway and predicts poorer survival. |
| Q37009889 | Screening for bladder cancer: a perspective |
| Q35998083 | Short and Long-Term Outcomes of Epidural or Intravenous Analgesia after Esophagectomy: A Propensity-Matched Cohort Study |
| Q36544712 | Should we screen for bladder cancer in a high-risk population?: A cost per life-year saved analysis |
| Q30870825 | Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial. |
| Q37157775 | Squamous cell carcinoma of the tonsil managed by conventional surgery and postoperative radiation |
| Q36606951 | Staged based directed surveillance of invasive bladder cancer following radical cystectomy: valuable and effective? |
| Q34984796 | Staging and reporting of urothelial carcinoma of the urinary bladder |
| Q38002454 | Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience. |
| Q38433829 | Survivin expression is associated with bladder cancer presence, stage, progression, and mortality |
| Q41750995 | TALL score for prediction of oncological outcomes after radical nephroureterectomy for high-grade upper tract urothelial carcinoma |
| Q41687794 | The Impact of Tumor Diameter and Tumor Necrosis on Oncologic Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy |
| Q60961908 | The impact of lymphovascular invasion in patients with prostate cancer following radical prostatectomy and its association with their clinicopathological features: An updated PRISMA-compliant systematic review and meta-analysis |
| Q53574858 | The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy. |
| Q37119414 | The impact of variant histology on the outcome of bladder cancer treated with curative intent |
| Q54517376 | The lymphatic system in clinically localized urothelial carcinoma of the bladder: morphologic characteristics and predictive value. |
| Q36418383 | The pathology of bladder cancer |
| Q38901440 | The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder |
| Q35804200 | The prognostic value of lymphovascular invasion in radical prostatectomy: a systematic review and meta-analysis |
| Q53359946 | The role of lymphovascular space invasion in renal cell carcinoma as a prognostic marker of survival after curative resection. |
| Q33247062 | The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer |
| Q33556162 | Tumour vascularization: sprouting angiogenesis and beyond |
| Q50967045 | Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome. |
| Q36640991 | Use of nomograms as predictive tools in bladder cancer. |
| Q35076360 | Use of nomograms for predictions of outcome in patients with advanced bladder cancer |
| Q39923620 | Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomy |
| Q85951003 | [Detection of lymphovascular invasion in urothelial carcinoma of the bladder through D2-40 immunostaining] |
Search more.